Contineum Therapeutics CTNM
NASDAQ CTNM
$13.03 +0.04 (+0.31%)
As of: Oct 2, 2026 · 11:43 AM EDT

Contineum Therapeutics (CTNM) Price to Book (2024 - 2026)

Updated

Contineum Therapeutics' Price to Book came in at 2.56 for Q2 2026, up 327.2% from 0.60 a year earlier and up 31.4% from the prior quarter.

Analysis

Contineum Therapeutics (CTNM) Price to Book (2024 - 2026) Analysis & Trends

For FY2025, Contineum Therapeutics' Price to Book was 1.63, down 14.5% from FY2024.

  • Going back by year, Price to Book was 1.91 in FY2024.
  • The Q2 2026 figure represents the highest quarterly Price to Book in data going back to Q2 2024.
  • Year-over-year, Price to Book increased in two of the last five quarters, with growth averaging 64.4%.
  • Business Quant data shows CTNM's Price to Book at 1.95 (Q1 2026), 1.63 (Q4 2025) and 1.90 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Contineum Therapeutics 502.82 Mn 502.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.56
Mar 31, 2026 1.95
Dec 31, 2025 1.63
Sep 30, 2025 1.90
Jun 30, 2025 0.60
Mar 31, 2025 0.98
Dec 31, 2024 1.91
Sep 30, 2024 2.34
Jun 30, 2024 2.08
API Access

Contineum Therapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=CTNM&period=max&api_key=YOUR_API_KEY